Within the reconstructive implant market, total ankle replacements are slowly replacing ankle fusion surgeries as the preferred gold standard for ankle arthritis patients due to:
In the trauma device space, smaller companies are attempting to compete with large market leaders by targeting niche indications, such as syndesmosis disruptions, Lisfranc fractures, and talus fractures, leading to the development of new products for such indications.
In the sports medicine device space, companies continue to focus their product development on:
Looking forward, medtech companies in this space should look into the following strategic considerations:
DRG makes it easier and quicker for you to get accurate, timely data and confident answers for your stakeholders and commercial planning needs.
Here are a few reasons leading medtech companies partner with DRG over other vendors: